^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SQZ-PBMC-HPV

    i
    Associations
    News

    Trials

    Company:
    STEMCELL Technologies
    Drug class:
    Immunostimulant, Cytotoxic T lymphocyte stimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors (SQZ-PBMC-HPV-101) (NCT04084951)
    Phase 1
    SQZ Biotechnologies
    Completed
    Last update posted :
    04/14/2023
    Initiation :
    01/28/2020
    Primary completion :
    02/09/2023
    Completion :
    02/09/2023
    HLA-A
    |
    HLA-A*02
    |
    Opdivo (nivolumab) • Tecentriq (atezolizumab) • Yervoy (ipilimumab) • SQZ-PBMC-HPV